Notification That Annual Report Will Be Submitted Late (nt 10-k)
March 31 2021 - 9:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
FORM
12b-25
NOTIFICATION OF LATE FILING
|
SEC FILE NUMBER
000-55144
CUSIP NUMBER
__________
|
(Check
one):
|
[X]
|
Form
10-K
|
[ ]
|
Form
20-F
|
[ ]
|
Form
11-K
|
[ ]
|
Form
10-Q
|
[ ]
|
Form
10-D
|
[ ]
|
Form
N-CEN
|
[ ]
|
Form
N-CSR
|
|
For
Period Ended:
|
December
31, 2020
|
|
[ ]
|
Transition
Report on Form 10-K
|
|
[ ]
|
Transition
Report on Form 20-F
|
|
[ ]
|
Transition
Report on Form 11-K
|
|
[ ]
|
Transition
Report on Form 10-Q
|
|
For
the Transition Period Ended:
|
|
Read
Instructions (on back page) Before Preparing Form. Please Print or Type.
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained
herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
|
|
PART
I — REGISTRANT INFORMATION
|
|
NUTRALIFE
BIOSCIENCES, INC.
|
Full
Name of Registrant.
|
|
|
Former
Name if Applicable
|
|
6601
Lyons Road, Suite L-6
|
Address
of Principal Executive Office (Street and Number)
|
|
Coconut
Creek, FL 33073
|
City,
State and Zip Code:
|
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
[X]
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D,or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)
Certain
financial and other information necessary for an accurate and full completion of the Report could not be provided within the prescribed
time period without unreasonable effort or expense.
PART IV — OTHER INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
Edgar
Ward
|
|
888
|
|
509-8901
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If answer is no, identify report(s).
|
Yes
[ ] No [X]
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
Yes
[ ] No [X]
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
|
NUTRALIFE
BIOSCIENCES, INC.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date:
|
March
31, 2021
|
|
By:
|
/s/
Edgar Ward
|
|
|
|
|
Edgar
Ward, Chief Executive Officer
|
NutraLife Biosciences (CE) (USOTC:NLBS)
Historical Stock Chart
From Aug 2024 to Sep 2024
NutraLife Biosciences (CE) (USOTC:NLBS)
Historical Stock Chart
From Sep 2023 to Sep 2024